Lentivector integration sites in ependymal cells from a model of metachromatic leukodystrophy: Non-b dna as a new factor influencing integration

Molecular Therapy Nucleic Acids

Volumn 3, Issue , 2014, Pages e187-

  McAllister, Robert G ^a   Liu, Jiahui ^b   Woods, Matthew W ^a   Tom, Sean K ^a   Rupar, Anthony ^b   Barr, Stephen D ^a  

^a WESTERN UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CEREBROSIDE SULFATASE; DNA B; GENOMIC DNA; GREEN FLUORESCENT PROTEIN; GUANINE QUADRUPLEX; LENTIVIRUS VECTOR; NON B DNA; RESTRICTION ENDONUCLEASE; SATELLITE DNA; UNCLASSIFIED DRUG; RETROVIRUS VECTOR; SINGLE STRANDED DNA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CENTRAL NERVOUS SYSTEM; CHOROID PLEXUS; CONTROLLED STUDY; CPG ISLAND; DIGESTION; DNA FLANKING REGION; DNA INTEGRATION; DNA ISOLATION; DNA SEQUENCE; DNA STRUCTURE; EPENDYMA CELL; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HELA CELL LINE; HUMAN; HUMAN CELL; HUMAN GENOME; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOFLUORESCENCE MICROSCOPY; INTERSPERSED REPEAT; LATERAL BRAIN VENTRICLE; MALE; METACHROMATIC LEUKODYSTROPHY; MOUSE; NONHUMAN; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TISSUE SECTION; TRANSCRIPTION INITIATION SITE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD BRAIN BARRIER; CARCINOGENESIS; LENTIVIRINAE; PROTEIN SECONDARY STRUCTURE; WILD TYPE;

EID: 84907316610     PISSN: None     EISSN: 21622531     Source Type: Journal    
DOI: 10.1038/mtna.2014.39     Document Type: Article

References (66)

1. Peng, L and Suzuki, K (1987). Ultrastructural study of neurons in metachromatic leukodystrophy. Clin Neuropathol 6: 224-230.
2. Sevin, C, Aubourg, P and Cartier, N (2007). Enzyme, cell and gene-based therapies for metachromatic leukodystrophy. J Inherit Metab Dis 30: 175-183.
3. Sevin, C, Benraiss, A, Van Dam, D, Bonnin, D, Nagels, G, Verot, L et al. (2006). Intracerebral adeno-associated virus-mediated gene transfer in rapidly progressive forms of metachromatic leukodystrophy. Hum Mol Genet 15: 53-64.
4. Sevin, C, Verot, L, Benraiss, A, Van Dam, D, Bonnin, D, Nagels, G et al. (2007). Partial cure of established disease in an animal model of metachromatic leukodystrophy after intracerebral adeno-associated virus-mediated gene transfer. Gene Ther 14: 405-414.
5. Naldini, L, Blömer, U, Gallay, P, Ory, D, Mulligan, R, Gage, FH et al. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272: 263-267.
6. Biffi, A, De Palma, M, Quattrini, A, Del Carro, U, Amadio, S, Visigalli, I et al. (2004). Correction of metachromatic leukodystrophy in the mouse model by transplantation of genetically modified hematopoietic stem cells. J Clin Invest 113: 1118-1129.
7. Biffi, A, Capotondo, A, Fasano, S, del Carro, U, Marchesini, S, Azuma, H et al. (2006). Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits in mice. J Clin Invest 116: 3070-3082.
8. Biffi, A, Montini, E, Lorioli, L, Cesani, M, Fumagalli, F, Plati, T et al. (2013). Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy. Science 341: 1233158.
9. Kobayashi, Y, Watanabe, M, Okada, Y, Sawa, H, Takai, H, Nakanishi, M et al. (2002). Hydrocephalus, situs inversus, chronic sinusitis, and male infertility in DNA polymerase lambda-deficient mice: possible implication for the pathogenesis of immotile cilia syndrome. Mol Cell Biol 22: 2769-2776.
10. Taulman, PD, Haycraft, CJ, Balkovetz, DF and Yoder, BK (2001). Polaris, a protein involved in left-right axis patterning, localizes to basal bodies and cilia. Mol Biol Cell 12: 589-599.
11. Brody, SL, Yan, XH, Wuerffel, MK, Song, SK and Shapiro, SD (2000). Ciliogenesis and leftright axis defects in forkhead factor HFH-4-null mice. Am J Respir Cell Mol Biol 23: 45-51.
12. Roth, Y, Kimhi, Y, Edery, H, Aharonson, E and Priel, Z (1985). Ciliary motility in brain ventricular system and trachea of hamsters. Brain Res 330: 291-297.
13. Sands, MS and Haskins, ME (2008). CNS-directed gene therapy for lysosomal storage diseases. Acta Paediatr Suppl 97: 22-27.
14. Hacein-Bey-Abina, S, Von Kalle, C, Schmidt, M, McCormack, MP, Wulffraat, N, Leboulch, P et al. (2003). LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302: 415-419.
15. Hacein-Bey-Abina, S, von Kalle, C, Schmidt, M, Le Deist, F, Wulffraat, N, McIntyre, E et al. (2003). A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 348: 255-256.
16. Barr, SD, Ciuffi, A, Leipzig, J, Shinn, P, Ecker, JR and Bushman, FD (2006). HIV integration site selection: targeting in macrophages and the effects of different routes of viral entry. Mol Ther 14: 218-225.
17. Hacein-Bey-Abina, S, Garrigue, A, Wang, GP, Soulier, J, Lim, A, Morillon, E et al. (2008). Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest 118: 3132-3142.
18. Wang, GP, Garrigue, A, Ciuffi, A, Ronen, K, Leipzig, J, Berry, C et al. (2008). DNA bar coding and pyrosequencing to analyze adverse events in therapeutic gene transfer. Nucleic Acids Res 36: e49.
19. Stein, S, Ott, MG, Schultze-Strasser, S, Jauch, A, Burwinkel, B, Kinner, A et al. (2010). Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease. Nat Med 16: 198-204.
20. Wu, X, Li, Y, Crise, B and Burgess, SM (2003). Transcription start regions in the human genome are favored targets for MLV integration. Science 300: 1749-1751.
21. Cattoglio, C, Facchini, G, Sartori, D, Antonelli, A, Miccio, A, Cassani, B et al. (2007). Hot spots of retroviral integration in human CD34+ hematopoietic cells. Blood 110: 1770-1778.
22. Wang, GP, Berry, CC, Malani, N, Leboulch, P, Fischer, A, Hacein-Bey-Abina, S et al. (2010). Dynamics of gene-modified progenitor cells analyzed by tracking retroviral integration sites in a human SCID-X1 gene therapy trial. Blood 115: 4356-4366.
23. Ronen, K, Negre, O, Roth, S, Colomb, C, Malani, N, Denaro, M et al. (2011). Distribution of lentiviral vector integration sites in mice following therapeutic gene transfer to treat â-thalassemia. Mol Ther 19: 1273-1286.
24. Zapala, MA, Hovatta, I, Ellison, JA, Wodicka, L, Del Rio, JA, Tennant, R et al. (2005). Adult mouse brain gene expression patterns bear an embryologic imprint. Proc Natl Acad Sci USA 102: 10357-10362.
25. Johansson, PA, Irmler, M, Acampora, D, Beckers, J, Simeone, A and Götz, M (2013). The transcription factor Otx2 regulates choroid plexus development and function. Development 140: 1055-1066.
26. Bushman, F, Lewinski, M, Ciuffi, A, Barr, S, Leipzig, J, Hannenhalli, S et al. (2005). Genome-wide analysis of retroviral DNA integration. Nat Rev Microbiol 3: 848-858.
27. Ambrosi, A, Glad, IK, Pellin, D, Cattoglio, C, Mavilio, F, Di Serio, C et al. (2011). Estimated comparative integration hotspots identify different behaviors of retroviral gene transfer vectors. PLoS Comput Biol 7: e1002292.
28. Ikeda, T, Shibata, J, Yoshimura, K, Koito, A and Matsushita, S (2007). Recurrent HIV-1 integration at the BACH2 locus in resting CD4+ T cell populations during effective highly active antiretroviral therapy. J Infect Dis 195: 716-725.
29. Schröder, AR, Shinn, P, Chen, H, Berry, C, Ecker, JR and Bushman, F (2002). HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110: 521-529.
30. Romiguier, J, Ranwez, V, Douzery, EJ and Galtier, N (2010). Contrasting GC-content dynamics across 33 mammalian genomes: relationship with life-history traits and chromosome sizes. Genome Res 20: 1001-1009.
31. Kikin, O, D'Antonio, L and Bagga, PS (2006). QGRS Mapper: a web-based server for predicting G-quadruplexes in nucleotide sequences. Nucleic Acids Res 34: W676-W682.
32. Bochman, ML, Paeschke, K and Zakian, VA (2012). DNA secondary structures: stability and function of G-quadruplex structures. Nat Rev Genet 13: 770-780.
33. Svozil, D, Kalina, J, Omelka, M and Schneider, B (2008). DNA conformations and their sequence preferences. Nucleic Acids Res 36: 3690-3706.
34. Cer, RZ, Bruce, KH, Mudunuri, US, Yi, M, Volfovsky, N, Luke, BT et al. (2011). Non-B DB: a database of predicted non-B DNA-forming motifs in mammalian genomes. Nucleic Acids Res 39: D383-D391.
35. Cer, RZ, Donohue, DE, Mudunuri, US, Temiz, NA, Loss, MA, Starner, NJ et al. (2013). Non-B DB v2.0: a database of predicted non-B DNA-forming motifs and its associated tools. Nucleic Acids Res 41: D94-D100.
36. Bartholomae, CC, Arens, A, Balaggan, KS, Yáñez-Muñoz, RJ, Montini, E, Howe, SJ et al. (2011). Lentiviral vector integration profiles differ in rodent postmitotic tissues. Mol Ther 19: 703-710.
37. Ciuffi, A, Llano, M, Poeschla, E, Hoffmann, C, Leipzig, J, Shinn, P et al. (2005). A role for LEDGF/p75 in targeting HIV DNA integration. Nat Med 11: 1287-1289.
38. Lewinski, MK, Bisgrove, D, Shinn, P, Chen, H, Hoffmann, C, Hannenhalli, S et al. (2005). Genome-wide analysis of chromosomal features repressing human immunodeficiency virus transcription. J Virol 79: 6610-6619.
39. Lewinski, MK, Yamashita, M, Emerman, M, Ciuffi, A, Marshall, H, Crawford, G et al. (2006). Retroviral DNA integration: viral and cellular determinants of target-site selection. PLoS Pathog 2: e60.
40. Ciuffi, A, Mitchell, RS, Hoffmann, C, Leipzig, J, Shinn, P, Ecker, JR et al. (2006). Integration site selection by HIV-based vectors in dividing and growth-arrested IMR-90 lung fibroblasts. Mol Ther 13: 366-373.
41. Mitchell, RS, Beitzel, BF, Schroder, AR, Shinn, P, Chen, H, Berry, CC et al. (2004). Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol 2: E234.
42. Carteau, S, Hoffmann, C and Bushman, F (1998). Chromosome structure and human immunodeficiency virus type 1 cDNA integration: centromeric alphoid repeats are a disfavored target. J Virol 72: 4005-4014.
43. Allen, MJ, Jeffreys, AJ, Surani, MA, Barton, S, Norris, ML and Collick, A (1994). Tandemly repeated transgenes of the human minisatellite MS32 (D1S8), with novel mouse gamma satellite integration. Nucleic Acids Res 22: 2976-2981.
44. Hawrylycz, MJ, Lein, ES, Guillozet-Bongaarts, AL, Shen, EH, Ng, L, Miller, JA et al. (2012). An anatomically comprehensive atlas of the adult human brain transcriptome. Nature 489: 391-399.
45. Kang, HJ, Kawasawa, YI, Cheng, F, Zhu, Y, Xu, X, Li, M et al. (2011). Spatio-temporal transcriptome of the human brain. Nature 478: 483-489.
46. Lein, ES, Hawrylycz, MJ, Ao, N, Ayres, M, Bensinger, A, Bernard, A et al. (2007). Genome-wide atlas of gene expression in the adult mouse brain. Nature 445: 168-176.
47. Wu, X, Li, Y, Crise, B, Burgess, SM and Munroe, DJ (2005). Weak palindromic consensus sequences are a common feature found at the integration target sites of many retroviruses. J Virol 79: 5211-5214.
48. Bor, YC, Miller, MD, Bushman, FD and Orgel, LE (1996). Target-sequence preferences of HIV-1 integration complexes in vitro. Virology 222: 283-288.
49. Pruss, D, Reeves, R, Bushman, FD and Wolffe, AP (1994). The influence of DNA and nucleosome structure on integration events directed by HIV integrase. J Biol Chem 269: 25031-25041.
50. Fitzgerald, ML and Grandgenett, DP (1994). Retroviral integration: in vitro host site selection by avian integrase. J Virol 68: 4314-4321.
51. Pryciak, PM, Sil, A and Varmus, HE (1992). Retroviral integration into minichromosomes in vitro. EMBO J 11: 291-303.
52. Mirkin, SM (2006). DNA structures, repeat expansions and human hereditary disorders. Curr Opin Struct Biol 16: 351-358.
53. Wells, RD, Dere, R, Hebert, ML, Napierala, M and Son, LS (2005). Advances in mechanisms of genetic instability related to hereditary neurological diseases. Nucleic Acids Res 33: 3785-3798.
54. Sinden, RR (1994). DNA Structure and Function, Academic Press.
55. Ho, PS (1994). The non-B-DNA structure of d(CA/TG)n does not differ from that of Z-DNA. Proc Natl Acad Sci USA 91: 9549-9553.
56. Wahls, WP, Wallace, LJ and Moore, PD (1990). The Z-DNA motif d(TG)30 promotes reception of information during gene conversion events while stimulating homologous recombination in human cells in culture. Mol Cell Biol 10: 785-793.
57. Tsutsui, KM, Sano, K, Hosoya, O, Miyamoto, T and Tsutsui, K (2011). Nuclear protein LEDGF/p75 recognizes supercoiled DNA by a novel DNA-binding domain. Nucleic Acids Res 39: 5067-5081.
58. Bacolla, A, Larson, JE, Collins, JR, Li, J, Milosavljevic, A, Stenson, PD et al. (2008). Abundance and length of simple repeats in vertebrate genomes are determined by their structural properties. Genome Res 18: 1545-1553.
59. Pruss, D, Bushman, FD and Wolffe, AP (1994). Human immunodeficiency virus integrase directs integration to sites of severe DNA distortion within the nucleosome core. Proc Natl Acad Sci USA 91: 5913-5917.
60. Bushman, FD (1994). Tethering human immunodeficiency virus 1 integrase to a DNA site directs integration to nearby sequences. Proc Natl Acad Sci USA 91: 9233-9237.
61. Weidhaas, JB, Angelichio, EL, Fenner, S and Coffin, JM (2000). Relationship between retroviral DNA integration and gene expression. J Virol 74: 8382-8389.
62. Bor, YC, Bushman, FD and Orgel, LE (1995). In vitro integration of human immunodeficiency virus type 1 cDNA into targets containing protein-induced bends. Proc Natl Acad Sci USA 92: 10334-10338.
63. Pryciak, PM and Varmus, HE (1992). Nucleosomes, DNA-binding proteins, and DNA sequence modulate retroviral integration target site selection. Cell 69: 769-780.
64. Ciuffi, A and Barr, SD (2011). Identification of HIV integration sites in infected host genomic DNA. Methods 53: 39-46.
65. Langmead, B and Salzberg, SL (2012). Fast gapped-read alignment with Bowtie 2. Nat Methods 9: 357-359.
66. Quinlan, AR and Hall, IM (2010). BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26: 841-842.